BioSpace News Archive

Genetown

ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023

ProQR Therapeutics NV. announced a presentation at the Oligonucleotide and Peptide Therapeutics conference, May 7-10, 2023 in San Diego, CA, USA.

May 9, 2023
·
4 min read
Business

Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

Kala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, reported financial results for the first quarter ended March 31, 2023 and provided a corporate update.

May 9, 2023
·
12 min read
Press Releases

TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog

TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, has launched its newest cap analog, CleanCap® M6.

May 9, 2023
·
5 min read
Drug Development

FDA Removes Partial Clinical Hold on Salarius Pharmaceuticals’ Phase 1/2 Clinical Trial with Seclidemstat in Patients with Ewing Sarcoma

Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) announces that the U.S. Food and Drug Administration (FDA) has removed its partial clinical hold on Salarius’ Phase 1/2 Ewing sarcoma clinical trial evaluating seclidemstat, Salarius’ novel oral, reversible, targeted LSD1 inhibitor.

May 9, 2023
·
10 min read
Business

Engitix Announces Appointment of Sonia Quaratino, M.D., Ph.D., as Independent Non-executive Director

Engitix Ltd announces the appointment of Sonia Quaratino, M.D., PH.D., to its Board of Directors, as an independent non-executive director.

May 9, 2023
·
3 min read
Biotech Beach

PUR Biologics Begins Shipment of its Breakthrough Product PURbonedough(TM)

PUR Biologics, an innovative biotech company, and wholly-owned subsidiary of HippoFi, Inc. (OTC PINK:ORHB), today has unveiled its latest product, PURbonedough™, to further expand its leadership into the burgeoning spine biologics market.

May 9, 2023
·
2 min read
MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy Participants

MindBio Therapeutics Corp. is pleased to announce its scientific collaborators have recently published their first Peer Reviewed Paper in Biological Psychiatry, an official journal of Psychiatric Neuroscience and Therapeutics.

May 9, 2023
·
5 min read
Business

RadNet Reports First Quarter Financial Results with Record First Quarter Revenue and Adjusted EBITDA(1) from Imaging Center Operations and Revises Upwards 2023 Financial Guidance Ranges for Revenue and Adjusted EBITDA(1)

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 363 owned and operated outpatient imaging centers, reported financial results for its first quarter of 2023.

May 9, 2023
·
25 min read
Lone Star Bio

The Caris Precision Oncology Alliance Welcomes Yale Cancer Center

Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced that Yale Cancer Center has joined the Caris Precision Oncology Alliance™.

May 9, 2023
·
4 min read
Business

Novavax Reports First Quarter 2023 Financial Results and Operational Highlights

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, announced its financial results and operational highlights for the first quarter ended March 31, 2023.

May 9, 2023
·
14 min read